Advances in therapy
-
Advances in therapy · Mar 2009
Randomized Controlled Trial Multicenter StudyCost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Transcranial magnetic stimulation (TMS) is a novel antidepressant therapy shown to be effective and safe in pharmacotherapy-resistant major depression. The incremental cost-effectiveness and the direct cost burden compared with sham treatment were estimated, and compared with the current standard of care. ⋯ TMS is a cost-effective treatment for patients who have failed to receive sufficient benefit from initial antidepressant pharmacotherapy. When used at earlier levels of treatment resistance, significant cost savings may be expected relative to the current standard of care.